JNJ

225.54

-0.03%↓

UNH

370.35

+1.35%↑

TMO

465.79

-0.01%↓

ISRG

450.79

-1.5%↓

ABT

86.59

-2.53%↓

JNJ

225.54

-0.03%↓

UNH

370.35

+1.35%↑

TMO

465.79

-0.01%↓

ISRG

450.79

-1.5%↓

ABT

86.59

-2.53%↓

JNJ

225.54

-0.03%↓

UNH

370.35

+1.35%↑

TMO

465.79

-0.01%↓

ISRG

450.79

-1.5%↓

ABT

86.59

-2.53%↓

JNJ

225.54

-0.03%↓

UNH

370.35

+1.35%↑

TMO

465.79

-0.01%↓

ISRG

450.79

-1.5%↓

ABT

86.59

-2.53%↓

JNJ

225.54

-0.03%↓

UNH

370.35

+1.35%↑

TMO

465.79

-0.01%↓

ISRG

450.79

-1.5%↓

ABT

86.59

-2.53%↓

Inicio・Lista de Acciones・MiNK Therapeutics

Search

MiNK Therapeutics

Cerrado

11.33 -5.82

Resumen

Variación precio

24h

Actual

Mínimo

11.33

Máximo

11.76

Métricas clave
By Trading Economics
Ingresos	-12B -12B
BPA	-0.56
Empleados	23
EBITDA	287K -2.6M

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 Meses	+201.72% upside

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	5.9M 55M
Apertura anterior	17.15
Cierre anterior	11.33

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

7.81 / 8.1 Soporte y Resistencia

MiNK Therapeutics Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

4 may 2026, 22:17 UTC

Ganancias

Australia's Westpac Lifts Dividend as 1st Half Profit Rises 2.7%

4 may 2026, 23:47 UTC

Ganancias

Grab Holdings 1Q Adj EBITDA $154.0M Vs. $106.0M >GRAB

4 may 2026, 23:45 UTC

Ganancias

Grab Holdings 1Q Rev $955.0M Vs. $773.0M >GRAB

4 may 2026, 23:45 UTC

Ganancias

Grab Holdings 1Q Net $120.0M Vs. Net $10.0M >GRAB

4 may 2026, 23:40 UTC

Charlas de Mercado

Gold Steady Amid Likely Technical Recovery -- Market Talk

4 may 2026, 22:44 UTC

Adquisiciones, fusiones, absorciones

Regis: Jim Beyer To Be Chief Executive of Combined Company

4 may 2026, 22:43 UTC

Adquisiciones, fusiones, absorciones

Regis: Russell Clark To Be Nonexecutive Chairman of Combined Company

4 may 2026, 22:42 UTC

Adquisiciones, fusiones, absorciones

Regis: Companies Expect to Realize Over A$500 Million in Corporate Tax Benefits

4 may 2026, 22:42 UTC

Adquisiciones, fusiones, absorciones

Regis: Combined Company to Have Strong, Debt-Free Balance Sheet; Significant Cash Generation

4 may 2026, 22:41 UTC

Adquisiciones, fusiones, absorciones

Regis: Combined Company to Have Annual Production of More Than 700,000 Oz

4 may 2026, 22:41 UTC

Adquisiciones, fusiones, absorciones

Regis: Pro Forma Market Capitalization About A$10.7 Billion

4 may 2026, 22:40 UTC

Adquisiciones, fusiones, absorciones

Regis: Shareholders to Own About 51% of Combined Company

4 may 2026, 22:40 UTC

Adquisiciones, fusiones, absorciones

Regis: Board Unanimously Endorsed, Supported Deal

4 may 2026, 22:40 UTC

Adquisiciones, fusiones, absorciones

Regis: Deal Unanimously Recommended by Vault Board

4 may 2026, 22:39 UTC

Adquisiciones, fusiones, absorciones

Regis: Vault Shareholders to Receive 0.6947 New Shares in Regis For Each Vault One Held

4 may 2026, 22:38 UTC

Adquisiciones, fusiones, absorciones

Regis Resources to Acquire All Ordinary Shares in Vault

4 may 2026, 22:38 UTC

Adquisiciones, fusiones, absorciones

Regis Resources, Vault Minerals Agree to Merger of Equals

4 may 2026, 22:37 UTC

Ganancias

Adquisiciones, fusiones, absorciones

Palantir Beats Forecasts With $1.63 Billion Quarter as Sales Accelerate -- 2nd Update

4 may 2026, 22:26 UTC

Ganancias

Adquisiciones, fusiones, absorciones

Palantir Beats Forecasts With $1.63 Billion Quarter as Sales Accelerate -- Update

4 may 2026, 22:02 UTC

Ganancias

Australia's Westpac Lifts Dividend as 1H Profit Rises 2.7%

4 may 2026, 22:00 UTC

Charlas de Mercado

BOC's Macklem: Conditions To Dictate Fuel-Price Response -- Market Talk

4 may 2026, 21:52 UTC

Ganancias

Westpac 1H Net Profit Ex-Notable Items A$3.48B Vs. A$3.46B>WBC.AU

4 may 2026, 21:50 UTC

Ganancias

Westpac: Some Sectors More Affected Than Others>WBC.AU

4 may 2026, 21:50 UTC

Ganancias

Westpac: Economic Impact of Middle East Conflict to Continue Through Year>WBC.AU

4 may 2026, 21:49 UTC

Ganancias

Westpac 1H Provision for Expected Credit Losses A$4.68B Vs. A$4.58B>WBC.AU

4 may 2026, 21:44 UTC

Ganancias

Westpac 1H Australia Lending Up 8% on Year>WBC.AU

4 may 2026, 21:44 UTC

Ganancias

Westpac 1H Australia Business Lending Up 16% on Year>WBC.AU

4 may 2026, 21:43 UTC

Ganancias

Westpac 1H Core Net Interest Margin 1.78% Vs. 1.80%>WBC.AU

4 may 2026, 21:41 UTC

Ganancias

Westpac 1H Australian Home Lending Up 7% on Year Excluding RAMS Portfolio>WBC.AU

4 may 2026, 21:40 UTC

Ganancias

Westpac 1H Credit Impairment Charge 10 Bps of Average Loans Vs. 6 Bps>WBC.AU

Comparación entre iguales

Cambio de precio

MiNK Therapeutics previsión

Precio Objetivo

By TipRanks

201.72% repunte

Estimación a 12 Meses

Media 35 USD 201.72%

Máximo 35 USD

Mínimo 35 USD

De acuerdo con 1 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para MiNK Therapeutics Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

1 ratings

1

Comprar

0

Mantener

0

Vender

De acuerdo con 1 analistas que ofrecen calificaciones bursátiles a para MiNK Therapeutics Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

7.81 / 8.1Soporte y Resistencia

Recent bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

There is one bearish event.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Otras acciones del sector

JNJ

Johnson and Johnson

225.54

UNH

UnitedHealth Group Inc

370.35

TMO

Thermo Fisher Scientific Inc

465.79

ISRG

Intuitive Surgical Inc

450.79

ABT

Abbott Laboratories

86.59

Live chat